IBRX
ImmunityBio, Inc.NASDAQStock$8.13+0.41 (+5.31%)Mkt Cap 8.5BP/E —Div Yield —Beta 0.13Vol 10.6MAvg Vol 8.6M
52W$1.98
$11.55
ETFs That Hold IBRX (ImmunityBio, Inc.)
1M
+0.74%
3M
+12.60%
6M
-17.29%
YTD
+302.48%
1Y
+259.73%
3Y
+392.73%
5Y
-25.14%
ETFs That Hold IBRX
ImmunityBio, Inc. is held by 69 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| SMMD | iShares Russell 2500 ETF | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.09% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% |
| FHLC | Fidelity MSCI Health Care Index ETF | 0.04% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.20% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.09% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.09% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.28% |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.24% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.11% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.07% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.01% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.54% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.03% |
| GERM | ETFMG Treatments, Testing and Advancements ETF | 3.14% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.13% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.06% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold IBRX?
ImmunityBio, Inc. (IBRX) is held by 69 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds IBRX?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $10.60B in AUM holds 0.91% of its portfolio in IBRX, representing $94.9M in market value.
What percentage of CNCR is IBRX?
IBRX makes up 3.28% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is IBRX in the S&P 500?
IBRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.